Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Conferences

03 May 2020 - 07 May 2020

2020 ARVO Annual Meeting, Baltimore (MD), US – cancelled

25 Apr 2020 - 01 May 2020

2020 AAN Annual Meeting, Toronto, Canada – canceled due to COVID-19

19 Apr 2020 - 21 Apr 2020

H.C. Wainwright Global Life Sciences Conference, London, UK – cancelled

03 March 2020

GenSight Biologics announces presentation of bilateral visual recovery from GS010 (LUMEVOQ™) Phase III trials at the 46th annual meeting of NANOS

15 Apr 2020 - 17 Apr 2020

2020 Cell & Gene Meeting on the Mediterranean, Barcelona, Spain – cancelled

23 Mar 2020 - 25 Mar 2020

Bio Europe Spring, Paris, France

07 Mar 2020 - 12 Mar 2020

46th NANOS Annual Meeting, Amelia Island, Florida, US

13 Jan 2020 - 16 Jan 2020

38th Annual J.P. Morgan Healthcare Conference, San Francisco (CA), USA

22 Oct 2019 - 25 Oct 2019

ESGCT 27th Annual Congress, Barcelona (Spain)

17 Oct 2019 - 19 Oct 2019

EVER 2019, Nice (FR)

  • View previous 9 articles
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page